rs1154510

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002150.3(HPD):​c.97A>G​(p.Thr33Ala) variant causes a missense change. The variant allele was found at a frequency of 0.866 in 1,607,144 control chromosomes in the GnomAD database, including 604,622 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T33T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.88 ( 59147 hom., cov: 32)
Exomes 𝑓: 0.86 ( 545475 hom. )

Consequence

HPD
NM_002150.3 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.23

Publications

48 publications found
Variant links:
Genes affected
HPD (HGNC:5147): (4-hydroxyphenylpyruvate dioxygenase) The protein encoded by this gene is an enzyme in the catabolic pathway of tyrosine. The encoded protein catalyzes the conversion of 4-hydroxyphenylpyruvate to homogentisate. Defects in this gene are a cause of tyrosinemia type 3 (TYRO3) and hawkinsinuria (HAWK). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
HPD Gene-Disease associations (from GenCC):
  • tyrosinemia type III
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • hawkinsinuria
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.099031E-6).
BP6
Variant 12-121857429-T-C is Benign according to our data. Variant chr12-121857429-T-C is described in ClinVar as Benign. ClinVar VariationId is 802899.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.952 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPDNM_002150.3 linkc.97A>G p.Thr33Ala missense_variant Exon 4 of 14 ENST00000289004.8 NP_002141.2
HPDNM_001171993.2 linkc.-21A>G 5_prime_UTR_variant Exon 6 of 16 NP_001165464.1
TIALDXR_002957437.2 linkn.395-190T>C intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPDENST00000289004.8 linkc.97A>G p.Thr33Ala missense_variant Exon 4 of 14 1 NM_002150.3 ENSP00000289004.4

Frequencies

GnomAD3 genomes
AF:
0.880
AC:
133757
AN:
152062
Hom.:
59095
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.960
Gnomad AMI
AF:
0.916
Gnomad AMR
AF:
0.796
Gnomad ASJ
AF:
0.895
Gnomad EAS
AF:
0.861
Gnomad SAS
AF:
0.852
Gnomad FIN
AF:
0.769
Gnomad MID
AF:
0.915
Gnomad NFE
AF:
0.869
Gnomad OTH
AF:
0.875
GnomAD2 exomes
AF:
0.845
AC:
212430
AN:
251396
AF XY:
0.848
show subpopulations
Gnomad AFR exome
AF:
0.963
Gnomad AMR exome
AF:
0.728
Gnomad ASJ exome
AF:
0.892
Gnomad EAS exome
AF:
0.863
Gnomad FIN exome
AF:
0.779
Gnomad NFE exome
AF:
0.868
Gnomad OTH exome
AF:
0.855
GnomAD4 exome
AF:
0.865
AC:
1258202
AN:
1454964
Hom.:
545475
Cov.:
33
AF XY:
0.865
AC XY:
626288
AN XY:
724188
show subpopulations
African (AFR)
AF:
0.965
AC:
32214
AN:
33370
American (AMR)
AF:
0.735
AC:
32856
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.890
AC:
23217
AN:
26100
East Asian (EAS)
AF:
0.840
AC:
33313
AN:
39664
South Asian (SAS)
AF:
0.847
AC:
72914
AN:
86116
European-Finnish (FIN)
AF:
0.779
AC:
41555
AN:
53372
Middle Eastern (MID)
AF:
0.905
AC:
5201
AN:
5750
European-Non Finnish (NFE)
AF:
0.872
AC:
964311
AN:
1105728
Other (OTH)
AF:
0.875
AC:
52621
AN:
60146
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
8548
17097
25645
34194
42742
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21144
42288
63432
84576
105720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.880
AC:
133865
AN:
152180
Hom.:
59147
Cov.:
32
AF XY:
0.874
AC XY:
65025
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.960
AC:
39875
AN:
41536
American (AMR)
AF:
0.796
AC:
12154
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.895
AC:
3109
AN:
3472
East Asian (EAS)
AF:
0.861
AC:
4447
AN:
5166
South Asian (SAS)
AF:
0.852
AC:
4110
AN:
4826
European-Finnish (FIN)
AF:
0.769
AC:
8137
AN:
10576
Middle Eastern (MID)
AF:
0.918
AC:
270
AN:
294
European-Non Finnish (NFE)
AF:
0.869
AC:
59073
AN:
68006
Other (OTH)
AF:
0.877
AC:
1855
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
808
1616
2424
3232
4040
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.872
Hom.:
229693
Bravo
AF:
0.886
TwinsUK
AF:
0.879
AC:
3261
ALSPAC
AF:
0.880
AC:
3391
ESP6500AA
AF:
0.956
AC:
4212
ESP6500EA
AF:
0.873
AC:
7505
ExAC
AF:
0.850
AC:
103217
Asia WGS
AF:
0.870
AC:
3024
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hawkinsinuria Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tyrosinemia type III;C2931042:Hawkinsinuria Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tyrosinemia type III Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.042
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
11
DANN
Benign
0.75
DEOGEN2
Benign
0.0033
T
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.065
N
LIST_S2
Benign
0.44
T
MetaRNN
Benign
0.0000021
T
MetaSVM
Benign
-0.95
T
PhyloP100
4.2
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
3.8
N
REVEL
Benign
0.19
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Vest4
0.037
MPC
0.36
ClinPred
0.020
T
GERP RS
5.5
gMVP
0.29
Mutation Taster
=238/62
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1154510; hg19: chr12-122295335; COSMIC: COSV56641491; COSMIC: COSV56641491; API